Pharma & health

1. Monday 26 October 2026In Madrid, lung cancer loses groundAt Europe’s cancer congress, Amgen and Roche cut the risk of death by half, or nearly.
2. Friday 23 October 2026The vaccine against melanomaModerna and Merck’s personalised vaccine cuts the risk of relapse by 42%; the share price drops 25%.
3. Tuesday 20 October 2026When the stock market takes refuge in the drugmakersFrom 12 to 16 October, US inflation rattled the markets. The big laboratories rose, the small biotechs sank. The week explained without jargon.
4. Saturday 17 October 2026Polycystic kidney: 103 million for a one-time gene therapyCalifornian biotech Estuary comes out of stealth with 103 million dollars to treat the most common inherited kidney disease, which has only one dedicated drug.